Portfolio company
Aeromics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This pharmaceutical company develops an intravenous drug to treat brain swelling in patients suffering from severe ischemic stroke.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Biomedical Solutions
This company develops endovascular thrombus removal devices for healthcare providers to treat patients suffering from acute ischemic stroke.
Acticor Biotech
The company develops glenzocimab, a therapeutic antibody fragment for treating patients with acute ischemic stroke and other thrombotic diseases.
PULSED ASPIRATION SYSTEM
This company develops a pulsed aspiration system for medical professionals to remove blood clots in patients with acute ischemic stroke.
Aptatargets
The company develops aptamer-based therapeutic drugs for patients with acute ischemic stroke and other inflammatory or cardiovascular diseases.
Julier Medical
This company develops an expandable endovascular catheter platform and mechanical thrombectomy devices for clinicians to treat patients experiencing acute ischemic strokes.
StrokeDx
This company develops portable, non-invasive neuroimaging devices and software for rapid bedside stroke detection and monitoring for healthcare providers and emergency services.
Voyage Biomedical
This company develops selective brain cooling devices to reduce damage from strokes and cardiac arrests for healthcare providers and patients.
Anaconda Biomed
This medical technology company develops self-expanding funnel catheters for neurovascular mechanical thrombectomy procedures, serving hospitals and clinics treating patients with acute ischemic stroke.